Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.43 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.43 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.43 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.41 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.40 |
| ▸ | TOP1 | P11387 | 1/20 | 0.40 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.40 |
| ▸ | ABL1 | P00519 | 1/20 | 0.40 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.40 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.40 |
| ▸ | FLT1 | P17948 | 1/20 | 0.40 |
| ▸ | GRK5 | P34947 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28024938 | 0.86 | PRMT5 (0.42) | CYP2C19PRMT5WDR77CDK8PTGS1 | |
| SCHEMBL18421684 | 0.85 | PRMT5 (0.41) | ALOX15ALDH1A1MEN1KMT2AL3MBTL1 | |
| SCHEMBL17116599 | 0.85 | PRMT5 (0.47) | PRMT5WDR77CLK4GSK3BGRM5 | |
| SCHEMBL17116282 | 0.84 | PRMT5 (0.43) | ALOX15ALDH1A1MEN1KMT2AL3MBTL1 | |
| SCHEMBL18462115 | 0.84 | PRMT5 (0.44) | ALOX15ALDH1A1PRMT5WDR77LRRK2 | |
| SCHEMBL14735824 | 0.83 | CYP11B2 (0.51) | ALOX15ALDH1A1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL3711809 | 0.83 | KDM4E (0.45) | ALDH1A1MEN1KMT2ACYP1A2PRMT5 | |
| SCHEMBL17116724 | 0.83 | PRMT5 (0.43) | ALOX15PRMT5WDR77CLK4GSK3B | |
| SCHEMBL22290166 | 0.83 | ERBB2 (0.45) | ALDH1A1MEN1KMT2APRMT5WDR77 | |
| SCHEMBL17117023 | 0.83 | PRMT5 (0.46) | ALOX15ALDH1A1PRMT5WDR77CLK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119431259-A | Electron transport layer material and preparation method and application thereof | 吉林奥来德光电材料股份有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-116199699-A | Organic compound and application thereof | 奥来德(上海)光电材料科技有限公司 | 2023-06-02 | — | — | CN | disclosed |
| CN-112479986-A | Method for selective mono-diene alkylation reaction of aromatic compound based on activation of hydrocarbon and pyridine as guide group | 四川大学 | 2021-03-12 | — | — | CN | disclosed |
| EP-2268143-A2 | NOVEL PIPERIDINE DERIVATIVES AS INHIBITORS OF STEAROYL-COA DESATURASE | Forest Laboratories Holdings Limited (BM) | 2011-01-05 | — | — | EP | disclosed |
| WO-2009117676-A2 | NOVEL PIPERIDINE DERIVATIVES AS INHIBITORS OF STEAROYL-COA DESATURASE | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2009-09-24 | — | — | WO | disclosed |
| US-20050075375-A1 | Heterocyclic compounds for treating hepatitis C virus | ANADYS PHARMACEUTICALS, INC. (US) | 2005-04-07 | — | — | US | disclosed |
| WO-2004110351-A2 | HETEROCYCLIC COMPOUNDS FOR TREATING HEPATITIS C VIRUS | ANADYS PHARMACEUTICALS, INC. (US) | 2004-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050075375-A1 | Heterocyclic compounds for treating hepatitis C virus | HAVCR2, HCCS, LIPC | ALOX15 1495/4885ALDH1A1 287/4885MEN1 3473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.